Navigation Links
Clinical Study Shows Regenecare Relieves Pain and Itching of Skin,Rashes Caused by Widely Used Cancer Drugs

IRVING, Texas--(BUSINESS WIRE)--Jul 11, 2007 - The Journal of the American Society of Clinical Oncology has published the early results of a clinical study conducted by Dr. Siu-Fun Wong, and her colleagues, which concluded that the topical gel, Regenecare(R), caused a statistically significant reduction in the pain and itching of a rash that results from the use of anti-cancer drugs known as EGFR inhibitors. This ongoing supportive care trial is listed on the National Cancer Institute Clinical Trials website (www.cancer.gov).

Paul Miller, President of MPM Medical, stated, "EGFR inhibitors form a group of drugs, sold by several pharmaceutical companies, which are effective in the treatment of cancer. However, after a few weeks of use, an acne-like rash often appears on the face, neck, back, hands, and/or legs resulting in severe pain and itching for the patient. We know of no other evidence-based topical applications reported in the scientific literature shown to help manage rash symptoms caused by EGFR drugs."

Regenecare(R) is a proprietary product of MPM Medical, Inc., a wholly owned subsidiary of RBC Life Sciences, Inc. (OTCBB:RBCL).

MPM Medical develops and markets a line of prescription and nonprescription products for wound management, through medical-surgical dealers, to nursing homes, hospitals, and cancer clinics.

The statements above, other than statements of historical facts, may be forward-looking. Actual events will be dependent upon a number of factors and risks including but not limited to changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission.

Contact

RBC Life Sciences, Inc.
Steve Brown, CFO, 972-893 4000
steveb@rbcls.com
www.mpmmedicalinc.com


'"/>




Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
3. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/18/2018)... ... 18, 2018 , ... Physicians with Georgia Urology, the largest ... nationwide using Blue Light Cystoscopy with Cysview. This assists in detecting papillary cancer ... the only FDA-approved imaging agent for use with blue-light cystoscopy. , Georgia Urology ...
(Date:10/17/2018)... (PRWEB) , ... October 17, 2018 , ... ... Centers, has recently published a new technique documenting the use of placental based ... dental implants. According to Dr. Holtzclaw, “At our DIA Dental Implant Center ...
(Date:10/17/2018)... (PRWEB) , ... October 17, 2018 , ... ... Commission for Health Care (ACHC) President and CEO José Domingos to its board ... welcome José Domingos to our Board of Directors, whose broad and varied stakeholder ...
Breaking Medicine Technology:
(Date:10/17/2018)... ... ... The Jacobs & Cushman San Diego Food Bank’s CEO, James Floros, was ... its Board of Directors. , California Association of Food Banks (CAFB) is an ... member food banks with a range of support services, direct service programs and advocates ...
(Date:10/16/2018)... ... October 16, 2018 , ... With a petition (case CJ-2018-04177) ... Graves McLain PLLC joins a series of lawsuits filed in states around the country ... at Massage Envy locations by Massage Envy’s massage therapists. , This lawsuit alleges ...
(Date:10/16/2018)... ... October 16, 2018 , ... Sheba Vine, JD, CPCO, Vice ... law, writes frequently on employment law matters and has contributed articles to Compliance ... Health Care Compliance Professional's Manual titled “Navigating the Evolving Marijuana Landscape” to serve ...
(Date:10/13/2018)... ... , ... At HEI Health, we believe tomorrow’s healthcare can be made affordable ... Healthcare CXO Fall Summit by Marcus Evans. HEI will be hosting an exclusive round ... with leading healthcare providers. , Marcus Evans National Healthcare CXO Summit is the ...
(Date:10/11/2018)... CHURCH, Va. (PRWEB) , ... October 11, 2018 ... ... and services, today announced the acquisition of J.Lodge, an industry leader in contact ... story —a lifelong survivor of a debilitating medical condition—J. Lodge supports alternative work ...
Breaking Medicine News(10 mins):